Cat. Number:  Rs-1027R  

Quantity size:  0.1ml （dilute with pH 7.4    0.01 M PBS or diluent of antibody）

 CYP2D6 抗體說(shuō)明書(shū) Anti-CYP2D6 抗體資料

 

Background: commonly prescribed drugs. Its substrates include debrisoquine, an adrenergic-blocking drug; sparteine and propafenone, both anti-arrythmic drugs; and amitryptiline, an anti-depressant. The gene is highly polymorphic in the population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Cytochrome P450 2D6 is the molecular target of autoantibodies against the "liver kidney microsomal antigen 1" （LKM 1）.
CYP2D6 抗體說(shuō)明書(shū) Anti-CYP2D6 抗體資料

 

Also known as: Cytochrome P450 2D6; CPD6; CYP2D; CYP2D6; CYP2DL1; CYPIID6; Cytochrome P450 family 2 subfamily D polypeptide 6; Debrisoquine 4 hydroxylase; EC 1.14.14.1; Flavoprotein linked monooxygenase; MGC120389; MGC120390; Microsomal monooxygenase; P450 DB1; P450C2D; P450DB1; Xenobiotic monooxygenase.

Specificity:      · anti- CYP2D6 is a rabbit monoclonal antibody unconjugated

 · specific for CYP2D6 of human, rat,mouse and chicken  

 · epitope mapping near the C terminus of CYP2D6 of human, rat mouse

and chicken

· human, rat, mouse and chicken cross reacted    

· use for western blotting, elisa, immunoprecipitation    

· Protein A affinity chromatography purification, purity :>95%

· Isotype: IgG   · mol wt: 48kDa

Application:     · Western blotting: 1:100-500

· Immunohistochemistry: 1:100-500

· ELISA: 1:500-1000

· Optimal working dilutions must be determined by the end user.

 

 

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.